Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients

Journal of Critical Care

Volumn 29, Issue 2, 2014, Pages 298-302

  Frazee, Erin N ^a   Personett, Heather A ^a   Leung, Jonathan G ^a   Nelson, Sarah ^a   Dierkhising, Ross A ^a   Bauer, Philippe R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alcohol withdrawal delirium; Alcoholic intoxication; Conscious sedation; Critical illness; Dexmedetomidine

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; LORAZEPAM; ALCOHOL; HYPNOTIC SEDATIVE AGENT;

ADULT; ALCOHOL WITHDRAWAL; ARTICLE; BRADYCARDIA; CASE STUDY; CLINICAL ARTICLE; CONTINUOUS INFUSION; CRITICAL ILLNESS; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; RETROSPECTIVE STUDY; SEDATION; BLOOD PRESSURE; CHEMICALLY INDUCED; DRUG EFFECTS; HEMODYNAMICS; MIDDLE AGED; PATHOPHYSIOLOGY; SUBSTANCE WITHDRAWAL SYNDROME;

ADULT; BENZODIAZEPINES; BLOOD PRESSURE; CRITICAL ILLNESS; DEXMEDETOMIDINE; ETHANOL; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTENSION; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84896695669     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.11.016     Document Type: Article

References (32)

1. Baldwin W.A., Rosenfeld B.A., Breslow M.J., et al. Substance abuse-related admissions to adult intensive care. Chest 1993, 103:21-25.
2. Monte R., Rabunal R., Casariego E., et al. Analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital. Alcohol Alcohol 2010, 45:151-158.
3. Sarff M., Gold J.A. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med 2010, 38:S494-S501.
4. Mayo-Smith M.F., Beecher L.H., Fischer T.L., et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 2004, 164:1405-1412.
5. Hack J.B., Hoffmann R.S., Nelson L.S. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early?. J Med Toxicol 2006, 2:55-60.
6. Gold J.A., Rimal B., Nolan A., et al. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med 2007, 35:724-730.
7. Dexmedetomidine full prescribing information 2010, 1-24. Hospira, Inc., Lake Forest, IL.
8. Muzyk A.J., Fowler J.A., Norwood D.K., et al. Role of alpha2-agonists in the treatment of acute alcohol withdrawal. Ann Pharmacother 2011, 45:649-657.
9. Riker R.R., Shehabi Y., Bokesch P.M., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009, 301:489-499.
10. Rovasalo A., Tohmo H., Aantaa R., et al. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry 2006, 28:362-363.
11. Maccioli G.A. Dexmedetomidine to facilitate drug withdrawal. Anesthesiology 2003, 98:575-577.
12. Baddigam K., Russo P., Russo J., et al. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 2005, 20:118-123.
13. Darrouj J., Puri N., Prince E., et al. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother 2008, 42:1703-1705.
14. Demuro J.P., Botros D.G., Wirkowski E., et al. Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case series. J Anesth 2012, 26:601-605.
15. Rayner S.G., Weinert C.R., Peng H., et al. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care 2012, 2:12.
16. Sullivan J.T., Sykora K., Schneiderman J., et al. Assessment of alcohol withdrawal: the Revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br J Addict 1989, 84:1353-1357.
17. Barr J., Zomorodi K., Bertaccini E.J., et al. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 2001, 95:286-298.
18. Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 2004, 65(Suppl 5):7-12.
19. Jacobi J., Fraser G.L., Coursin D.B., et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002, 30:119-141.
20. Swart E.L., Zuideveld K.P., de Jongh J., et al. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Br J Clin Pharmacol 2004, 57:135-145.
21. Pandharipande P., Shintani A., Peterson J., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006, 104:21-26.
22. Trompeo A.C., Vidi Y., Locane M.D., et al. Sleep disturbances in the critically ill patients: role of delirium and sedative agents. Minerva Anestesiol 2011, 77:604-612.
23. Obiora E., Hubbard R., Sanders R.D., et al. The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort. Thorax 2013, 68:163-170.
24. Horinek E.L., Kiser T.H., Fish D.N., et al. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Ann Pharmacother 2009, 43:1964-1971.
25. Spies C.D., Otter H.E., Huske B., et al. Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Intensive Care Med 2003, 29:2230-2238.
26. de Lima C.B., Sakai M., Latorre A.O., et al. Effects of different doses and schedules of diazepam treatment on lymphocyte parameters in rats. Int Immunopharmacol 2010, 10:1335-1343.
27. Laschi A., Descotes J., Tachon P., et al. Adverse influence of diazepam upon resistance to Klebsiella pneumoniae infection in mice. Toxicol Lett 1983, 16:281-284.
28. Gerlach A.T., Dasta J.F., Steinberg S., et al. A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients. J Crit Care 2009, 24:568-574.
29. Jones G.M., Murphy C.V., Gerlach A.T., et al. High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficacy and safety. Ann Pharmacother 2011, 45:740-747.
30. Baumgartner G.R., Rowen R.C. Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J 1991, 84:312-321.
31. Manhem P., Nilsson L.H., Moberg A.L., et al. Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms. Alcohol Clin Exp Res 1985, 9:238-243.
32. Hecksel K.A., Bostwick J.M., Jaeger T.M., et al. Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clin Proc 2008, 83:274-279.